Drug Approval | July 14, 2024
Suven Pharmaceuticals gets Form 483 from with two observations from USFDA for Casper Pharma
The company will address these observations within the stipulated timeline
The company will address these observations within the stipulated timeline
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
PEKK is a high-performance polymer family used in aerospace and other demanding markets
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Lupin updates on shipment of Mirabegron ER Tablets
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Subscribe To Our Newsletter & Stay Updated
